Publications and Presentations

Latest Presentation


June 3, 2020
Ohana Biosciences Presents Data Showing Its Novel Sperm Enhancement Treatment, SPERTILITY™, Increases Sperm Hyperactivation

Ohana presented pre-clinical data on their product candidate, SPERTILITY™, during the American Society of Andrology’s virtual poster session, showing that this novel sperm enhancement treatment significantly increases the hyperactivation of sperm, potentially leading to increased likelihood of pregnancy for couples using Assisted Reproductive Technology (ART).